Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$18.46 - $24.36 $1.93 Million - $2.55 Million
-104,780 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$17.66 - $28.92 $183,134 - $299,900
-10,370 Reduced 9.01%
104,780 $2.16 Million
Q4 2020

Feb 02, 2021

SELL
$23.25 - $37.73 $115,738 - $187,819
-4,978 Reduced 4.14%
115,150 $2.82 Million
Q3 2020

Nov 05, 2020

BUY
$3.74 - $28.74 $85,122 - $654,122
22,760 Added 23.38%
120,128 $3.4 Million
Q2 2020

Aug 12, 2020

BUY
$3.04 - $6.2 $216,046 - $440,621
71,068 Added 270.22%
97,368 $463,000
Q4 2019

Jan 27, 2020

BUY
$2.99 - $4.42 $78,637 - $116,246
26,300 New
26,300 $91,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $95.5M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.